NEW research employing Mendelian randomisation (MR) analysis has identified a potential causal relationship between lipid ...
The RNA inhibitor reduces levels of oxidized phospholipids, which are presumed to promote atherosclerosis, by more than 93%.
Apolipoprotein B concentration is the strongest lipid-associated predictor of cardiovascular events. However, in patients who require lipid-lowering therapy, LDL cholesterol is the primary ...
Hosted on MSN1y
Salmon's heart health benefits backed by science: A rich source of unique compounds, study revealsThe benefits include a reduction in total cholesterol, low-density lipoprotein cholesterol, triglycerides, and apolipoprotein B, an indicator of heart disease. Dietitians like Michelle ...
HDL-cholesterol (HDL-C), HDL2-cholesterol (HDL2-C), HDL3-cholesterol (HDL3-C), apolipoprotein A1 (Apo-A1), apolipoprotein B (Apo-B), and lipoprotein (a) (Lp(a)) were determined. Results: In study 1 ...
A new study published in the Journal of American Medical Association showed that the innovative small interfering RNA (siRNA) medication olpasiran (Amgen) can effectively reduce lipoprotein(a) ...
Finally, all statistical models included apo B to account for differences in the proatherogenic lipoprotein fraction. In the IDEAL study, we observed that plasma levels of HDL-C were indeed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback